1.Advances in insulin like growth factor binding protein 1 in the prognosis of acute myocardial infarction.
Lu HUI ; Pan HUI ; Gong FENG-YING
Acta Academiae Medicinae Sinicae 2011;33(1):22-24
Insulin-like growth factor (IGF) is closely associated with cardiovascular diseases. Low IGF-I level and high insulin-like growth factor binding protein-1 (IGFBP-1) level in serum can be used as a marker in predicting the long term morbidity and mortality of acute myocardial infarction (AMI). The article reviews the recent advances in IGFBP-1 in the prognosis of AMI.
Humans
;
Insulin-Like Growth Factor Binding Protein 1
;
blood
;
Insulin-Like Growth Factor I
;
metabolism
;
Myocardial Infarction
;
blood
;
Prognosis
2.Profile of Insulin, Growth Hormone and Insulin-like Growth Factors in Human Cord Blood According to Birth Weight.
Hye Young KIM ; Dae Yeol LEE ; Soo Chul CHO
Journal of the Korean Pediatric Society 1998;41(11):1484-1490
PURPOSE: Insulin-like growth factors (IGFs) are mitogenic peptides that are essential for fetal and maternal tissue growth during pregnancy. They circulate primarily with serum IGF-binding protein (IGFBP) which regulates the availability of IGFs to their specific target tissue. This study was performed to examine the relationships between birth weight and IGFs, insulin and growth hormone in the sera of cord blood. METHODS: Fetal serum samples were obtained by direct puncture of the umbilical cord and were stored at -20degrees C until assay. Serum IGF-I, insulin and growth hormone were measured by radioimmunoassay. IGF-II and IGFBP-1 were measured by immunoradiometric assay. RESULTS: The values of insulin, growth hormone, and IGFBP-1 in the cord blood did not significantly correlate with birth weight or gestational age. The values of IGF-I significantly correlated with gestational age (P<0.05). The correlation of IGF-I and birth weight was statistically significant (P<0.05). IGF-II in the sera of cord blood did not significantly correlate with birth weight. CONCLUSION: Cord blood IGF-I level strongly correlated with birth weight, which suggests that IGF-I may play an important role in fetal growth.
Birth Weight*
;
Fetal Blood*
;
Fetal Development
;
Gestational Age
;
Growth Hormone*
;
Humans*
;
Immunoradiometric Assay
;
Insulin*
;
Insulin-Like Growth Factor Binding Protein 1
;
Insulin-Like Growth Factor I
;
Insulin-Like Growth Factor II
;
Parturition*
;
Peptides
;
Pregnancy
;
Punctures
;
Radioimmunoassay
;
Somatomedins*
;
Umbilical Cord
4.A decrease in circulating levels of immunoreactive insulin-like growth factor binding protein-1 (IGFBP-1) after endometrial ablation using a gynecologicresectoscope.
Ki Hyun PARK ; Byung Seok LEE ; Jeong Yeon KIM ; Dong Jae CHO ; Chan Ho SONG ; Sang Joon LEE
Yonsei Medical Journal 1999;40(5):450-453
To determine how endometrium alone would contribute to maintaining the circulating levels of Insulin-like growth factor binding protein-1 in vivo, serum immunoreactive IGFBP-1 levels were measured in 19 patients undergoing endometrial ablation using gynecologic resectoscopy. After endometrial ablation there was a significant decrease in the mean levels of circulating IGFBP-1, which was not correlated with the menstrual cycle. This result indicates that the endometrium is one of the sources of the circulating IGFBP-1.
Adult
;
Endometrium/surgery*
;
Endoscopes
;
Female
;
Human
;
Insulin-Like Growth-Factor Binding Protein 1/blood*
;
Menstruation
;
Middle Age
5.Insulin-like growth factor I combining with number connection test for selecting subclinical hepatic encephalopathy.
Wei WU ; Shu ZHANG ; Yun-lin WU ; Rong-ping XI
Chinese Journal of Hepatology 2003;11(8):486-486
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Follow-Up Studies
;
Hepatic Encephalopathy
;
blood
;
diagnosis
;
etiology
;
Humans
;
Insulin-Like Growth Factor Binding Protein 1
;
Insulin-Like Growth Factor Binding Proteins
;
blood
;
Liver Cirrhosis
;
complications
;
Male
;
Middle Aged
;
Neuropsychological Tests
;
Pregnancy Proteins
;
blood
6.Study of umbilical cord blood adiponectin, IGF-I, IGFBP-1, insulin and leptin levels in small for gestational age neonates at birth.
Noh Mi CHOI ; Mi Hye PARK ; Young Joo KIM ; Jung Ja ANN ; Sun Hee CHUN
Korean Journal of Obstetrics and Gynecology 2009;52(4):420-428
OBJECTIVE: Intrauterine growth is influenced by multiple factors like genetic, nutritional, environmental and hormonal factors. As birth weight is reported to be related to perinatal morbidity and mortality, we aimed to compare umbilical cord blood adiponectin, IGF-I, IGFBP-1, insulin and leptin levels between small for gestational age (SGA) and appropriate for gestational age (AGA) neonates at birth to investigate the influence of these factors on birth weight and ponderal index. METHODS: We investigated retrospectively 30 pregnant women with SGA and 30 pregnant women with AGA who delivered at Ewha Womans University Hospital and their babies from January 2007 to December 2007. Fetal umbilical cord venous blood adiponectin, IGF-I, IGFBP-1, insulin and leptin levels from SGA and AGA neonates were obtained at the time of delivery. The definition used to identify cases of SGA was individual birth weight ratio of less than 10th percentile and the definition of ponderal index (PI) was [BW (g)/ (height (cm))3]x100. RESULTS: Umbilical cord blood adiponectin, IGF-I and IGF/IGFBP ratio were significantly lower (P<0.05) in SGA than AGA. And umbilical cord blood IGFBP-1 were significantly higher (P<0.05) in SGA than AGA. But there was no significant difference in umbilical cord blood insulin and leptin levels between SGA and AGA neonates. Positive correlation was noted between adiponectin and IGF-I, IGF/IGFBP ratio, insulin and leptin. Negative correlation was noted between adiponectin and IGFBP-1, IGF-I and IGFBP-1. On multiple regression analysis, adiponectin and IGF-I were significant factors associated with body weight (BW), but only IGFBP-1 was significant factor associated with PI. CONCLUSION: These results suggest that fetal adiponectin, IGF-I, IGFBP-1 may have an important role in regulation of intrauterine growth and we will expect that evaluation of adiponectin and IGF-I in SGA may be helpful in prediction of neonatal outcome, and IGFBP-1 may be useful in diagnosis of asymmetric intrauterine growth retardation (IUGR).
Adiponectin
;
Birth Weight
;
Body Weight
;
Female
;
Fetal Blood
;
Fetal Growth Retardation
;
Gestational Age
;
Humans
;
Infant, Newborn
;
Insulin
;
Insulin-Like Growth Factor Binding Protein 1
;
Insulin-Like Growth Factor I
;
Leptin
;
Parturition
;
Pregnant Women
;
Retrospective Studies
;
Umbilical Cord
7.Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer.
Bo JIANG ; Dong-Bo LIU ; Xin ZHANG ; Li-Li DU ; Cun-Zhi HAN
Chinese Journal of Gastrointestinal Surgery 2009;12(3):264-268
OBJECTIVETo study the association of the changes of serum insulin, insulin-like growth factor (IGF-1), insulin-like growth factor binding proteins(IGFBPs), body mass index (BMI), waist and hip circumference ratio(WHR) with the genesis of colorectal cancer.
METHODSSera from 244 colorectal cancer patients before operation, 371 patients after operation and 150 healthy subjects were assayed for insulin, leptin, IGF-1, IGFBP-1 and IGFBP-3 by the enzyme-linked immunosorbent assay. SPSS 13.0 statistics software was applied to analyze the data.
RESULTSThe serum levels of insulin, IGF-1 and the ratio of IGF-1/ IGFBP-3 in colorectal cancer patients before and after surgical treatment were significantly higher than those in controls. The serum levels of IGFBP-3 in patients before and after operation were significantly lower than those in controls, and the differences were significant(P=0.015,P=0.001, respectively). The BMI in colorectal carcinoma patients was not significantly different to the healthy controls(P>0.05). The WHR in colorectal carcinoma patients was higher than that in healthy subjects, and the difference was significant(P=0.003, P=0.035 respectively). The WHR in colon cancer patients was different to that in rectal cancer patients(P=0.046). The WHR and BMI in colon carcinoma patients were positively correlated with the serum insulin level and the value of IGF/IGFBP3. The WHR and BMI were negatively correlated with IGFBP3. The WHR and BMI were not correlated with IGF-1 and IGFBP1.
CONCLUSIONSThe serum insulin, IGF-1 levels and the value of IGF-1/IGFBP-3 are significantly increased in colorectal cancer patients, and serum IGFBP-3 level is markedly decreased, which may be related to the genesis of colorectal cancer, but are not correlated with the progress and improvement of colorectal cancer. Central adipositas may be a risk factor for the genesis of colon cancer.
Adult ; Aged ; Body Mass Index ; Case-Control Studies ; Colorectal Neoplasms ; metabolism ; Female ; Humans ; Insulin ; blood ; Insulin-Like Growth Factor Binding Protein 1 ; blood ; Insulin-Like Growth Factor Binding Protein 3 ; blood ; Insulin-Like Growth Factor I ; metabolism ; Leptin ; blood ; Male ; Middle Aged ; Risk Factors ; Waist-Hip Ratio
8.Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis.
Li-jian LIANG ; Shi-min LUO ; Wen-jie HU
Chinese Journal of Surgery 2005;43(11):697-701
OBJECTIVETo explore the effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 (GH/IGF-1) axis after partial hepatectomy in rats with liver cirrhosis.
METHODSSix normal rats severed as normal group, while 30 rats with liver cirrhosis were randomly divided into preoperation group, 1 day postoperative group, 8.5% Novamin PN for 5 days postoperative group, 10% Hepa PN for 5 days postoperative group and rhGH + 10% Hepa PN for 5 days postoperative group. Liver function, blood glucose and serum GH, IGF-1, IGFBP-3 were determined. ALB mRNA, IGF-1 mRNA and IGFBP-3 mRNA levels in liver tissues were detected by RT-PCR. Liver Ki67 immunohistochemistry staining was studied.
RESULTSCompared with the 8.5% Novamine PN group, serum ALT [(103 +/- 23) IU/L vs (154 +/- 45) IU/L], ALP [(571 +/- 92) IU/L vs (972 +/- 252) IU/L], GH [(1.55 +/- 0.12) ng/ml vs (1.81 +/- 0.11) ng/ml] level were lower (P < 0.05), serum IGF-1 [(966 +/- 55) ng/ml vs (813 +/- 43) ng/ml] and IGFBP-3 [(8.1 +/- 0.3) ng/ml vs (6.9 +/- 0.2) ng/ml] level and the expression of hepatic ALB mRNA (1.24 +/- 0.06 vs 1.02 +/- 0.09), IGF-1 mRNA (0.85 +/- 0.00 vs 0.60 +/- 0.03), IGFBP-3 mRNA (0.69 +/- 0.02 vs 0.58 +/- 0.09) were higher in the 10% Hepa PN group (P < 0.05), but there was no difference in liver Ki67 labeling index [(4.8 +/- 0.3)% vs (4.4 +/- 0.4%)] (P > 0.05). Compared with the 10% Hepa PN group, serum ALP [(434 +/- 41) IU/L vs (571 +/- 92) IU/L] was much lower (P < 0.05), serum ALB [(37.0 +/- 1.8) g/L vs (32.8 +/- 1.2) g/L], blood glucose [(7.6 +/- 1.3) mmol/L vs (4.9 +/- 0.7) mmol/L], GH [(3.00 +/- 0.61) ng/ml vs (1.55 +/- 0.12) ng/ml], IGF-1 [(1100 +/- 32) ng/ml vs (966 +/- 55) ng/ml], IGFBP-3 [(9.3 +/- 0.2) ng/ml vs (8.1 +/- 0.3) ng/ml] level, the expression of hepatic ALB mRNA (1.35 +/- 0.04 vs 1.24 +/- 0.06), IGF-1 mRNA (0.97 +/- 0.00 vs 0.85 +/- 0.00) and liver Ki67 labeling index [(5.4 +/- 0.3)% vs (4.8 +/- 0.3%)] were higher (P < 0.05) in the rhGH + 10% Hepa PN group.
CONCLUSIONSAmino acid solution and recombinant human growth hormone can influence the GH/IGF-1 axis in rats with liver cirrhosis. It may be helpful in selecting and evaluating nutrient by measuring the serum IGF-1 and IGFBP-3 level.
Amino Acids ; pharmacology ; therapeutic use ; Animals ; Human Growth Hormone ; pharmacology ; therapeutic use ; Insulin-Like Growth Factor Binding Protein 1 ; blood ; Insulin-Like Growth Factor Binding Protein 3 ; blood ; Insulin-Like Growth Factor I ; metabolism ; Liver Cirrhosis, Experimental ; blood ; therapy ; Male ; Parenteral Nutrition, Total ; methods ; Rats ; Rats, Sprague-Dawley ; Recombinant Proteins ; pharmacology ; therapeutic use
9.Insulin-like growth factor binding protein 1 and human embryonic development during 6 - 10 gestational weeks.
Qun FANG ; Yan-Xia WANG ; Yi ZHOU
Chinese Medical Journal 2004;117(4):488-491
BACKGROUNDInsulin-like growth factor binding protein-1 (IGFBP-1), which is a carrier of Insulin-like growth factors (IGFs) regulates the fetal development by working as an active factor controlling the combination of IGFs with their receptors. This study was designed to investigate the relationship between IGFBP-1 and human embryonic development during weeks 6 - 10 of gestation.
METHODSA total of 44 pregnant women with singleton pregnancy were divided into two groups: one with abnormal embryo development (n = 32) and the other with normal embryo development (n = 12). Enzyme-linked immunosorbent assay (ELISA) was employed to detect IGFBP-1 levels in maternal serum and decidual tissue. The expression of IGFBP-1 mRNA in deciduas was examined by reverse transcription polymerase chain reaction (RT-PCR) technique.
RESULTSThe level of IGFBP-1 protein in maternal serum was significantly higher in the abnormal group [(125.36 +/- 47.93) micro g/ml] than in the normal group [(70.72 +/- 21.21) micro g/ml]. Both of IGFBP-1 and IGFBP-1 mRNA in deciduas were higher in abnormal group [(1.60 +/- 1.39) micro g/ml and 1.66 +/- 1.64, respectively] than in the normal group [(0.35 +/- 0.23) micro g/ml and 0.40 +/- 0.20, respectively]. The level of IGFBP-1 in maternal serum was positively correlated with IGFBP-1 mRNA (r = 0.90, P < 0.05) and IGFBP-1 protein (r = 0.92, P < 0.05) in decidual tissue.
CONCLUSIONSDuring weeks 6 - 10 of gestation, abnormal embryonic development is correlated with elevated IGFBP-1. The level of IGFBP-1 in maternal serum is related to the concentrations of IGFBP-1 mRNA and IGFBP-1 in decidual tissue. The IGFBP-1 level in maternal serum may be used as a predictive marker to evaluate embryonic development.
Adult ; Decidua ; chemistry ; Embryonic and Fetal Development ; Female ; Gestational Age ; Humans ; Insulin-Like Growth Factor Binding Protein 1 ; analysis ; blood ; genetics ; Pregnancy ; RNA, Messenger ; analysis
10.Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth.
Dong Ho BAK ; Mi Ji CHOI ; Soon Re KIM ; Byung Chul LEE ; Jae Min KIM ; Eun Su JEON ; Wonil OH ; Ee Seok LIM ; Byung Cheol PARK ; Moo Joong KIM ; Jungtae NA ; Beom Joon KIM
The Korean Journal of Physiology and Pharmacology 2018;22(5):555-566
Human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) are used in tissue repair and regeneration; however, the mechanisms involved are not well understood. We investigated the hair growth-promoting effects of hUCB-MSCs treatment to determine whether hUCB-MSCs enhance the promotion of hair growth. Furthermore, we attempted to identify the factors responsible for hair growth. The effects of hUCB-MSCs on hair growth were investigated in vivo, and hUCB-MSCs advanced anagen onset and hair follicle neogeneration. We found that hUCB-MSCs co-culture increased the viability and up-regulated hair induction-related proteins of human dermal papilla cells (hDPCs) in vitro. A growth factor antibody array revealed that secretory factors from hUCB-MSCs are related to hair growth. Insulin-like growth factor binding protein-1 (IGFBP-1) and vascular endothelial growth factor (VEGF) were increased in co-culture medium. Finally, we found that IGFBP-1, through the co-localization of an IGF-1 and IGFBP-1, had positive effects on cell viability; VEGF secretion; expression of alkaline phosphatase (ALP), CD133, and β-catenin; and formation of hDPCs 3D spheroids. Taken together, these data suggest that hUCB-MSCs promote hair growth via a paracrine mechanism.
Alkaline Phosphatase
;
Alopecia
;
Cell Survival
;
Coculture Techniques
;
Fetal Blood*
;
Hair Follicle
;
Hair*
;
Humans*
;
In Vitro Techniques
;
Insulin-Like Growth Factor Binding Protein 1
;
Insulin-Like Growth Factor I
;
Intercellular Signaling Peptides and Proteins*
;
Mesenchymal Stromal Cells
;
Regeneration
;
Stem Cells*
;
Umbilical Cord*
;
Vascular Endothelial Growth Factor A